Filter
7632
Filtered Results: 7632
Text search:
number
of
patients
Featured
Recommendations
731
New Publications
1929
Language
Document type
No document type
4300
Studies & Reports
1174
Guidelines
1075
Manuals
385
Strategic & Response Plan
228
Fact sheets
168
Training Material
127
Situation Updates
98
Resource Platforms
24
Infographics
19
Online Courses
17
Brochures
15
Dashboards/Maps
1
Videos
1
Countries / Regions
India
433
Global
253
Kenya
212
South Africa
212
Sierra Leone
194
Liberia
178
Western and Central Europe
162
Ethiopia
152
Uganda
139
Nigeria
134
Africa
115
Malawi
114
Nepal
112
Latin America and the Carribbean
108
Tanzania
107
Zambia
97
Rwanda
96
Bangladesh
92
Myanmar / Burma
86
Ghana
85
Syria
82
Ukraine
79
Namibia
63
Philippines
57
Congo, Democratic Republic of
56
Eastern Europe
56
Russia
55
Guinea
54
Zimbabwe
48
West and Central Africa
48
South–East Asia Region
48
Lesotho
47
Cambodia
46
Mozambique
46
East and Southern Africa
45
Middle East and North Africa
44
Asia
43
South Sudan
41
Haiti
40
Germany
38
Indonesia
35
Senegal
34
Brazil
32
Botswana
31
Burkina Faso
30
Eastern Europe and Central Asia
29
Cameroon
27
Yemen
24
Benin
22
Eswatini/ Swaziland
21
Colombia
19
Venezuela
19
Pakistan
16
Western Pacific Region
16
USA
15
Madagascar
15
Mali
13
Central African Republic
13
Iraq
12
Afghanistan
12
Albania
12
Tajikistan
12
Thailand
11
Sudan
11
Peru
11
Georgia
11
Somalia
10
Lebanon
10
Sri Lanka
10
Jordan
9
Chile
9
Palestine
9
Southern Africa
9
Laos
9
Moldova
9
Vietnam
9
Côte d’Ivoire / Ivory Coast
8
Angola
8
Paraguay
8
North America
8
United Kingdom
8
China
7
North Macedonia
6
Bolivia
6
Armenia
6
Turkey
5
Chad
5
Argentina
5
Ecuador
5
Mexico
5
Kazakhstan
5
Jamaica
5
France
5
Guinea-Bissau
4
Togo
4
Gambia
4
Hungary
4
Bhutan
4
Poland
4
Kyrgyzstan
4
Spain
4
Saudi Arabia
3
Niger
3
Singapore
3
Papua New Guinea
3
Serbia
3
El Salvador
3
Greece
3
Libya
3
Canada
3
Timor Leste/ East Timor
3
Romania
3
Uzbekistan
3
Mauritius
3
Morocco
2
Egypt
2
Ireland
2
Switzerland
2
Burundi
2
Honduras
2
Guatemala
2
Other region
2
Bulgaria
2
Lithuania
2
Slovakia
2
Iran
2
Australia
2
Portugal
2
Malaysia
1
Mauritania
1
Austria
1
Nicaragua
1
Fiji
1
Solomon Islands
1
North Korea
1
Mongolia
1
Congo-Brazzaville
1
Qatar
1
Estonia
1
Gabon
1
Turkmenistan
1
Japan
1
Denmark
1
Belgium
1
Maldives
1
Tunisia
1
Norway
1
Belarus
1
French Guyana
1
Israel
1
Latvia
1
Authors & Publishers
Publication Years
Category
Countries
2849
Clinical Guidelines
692
Public Health
421
Women & Child Health
297
Key Resources
234
Capacity Building
163
Pharmacy & Technologies
102
Annual Report MEDBOX
2
Toolboxes
COVID-19
848
Mental Health
613
HIV
603
TB
496
Ebola
315
Caregiver
257
Rapid Response
255
AMR
248
NTDs
220
Conflict
180
NCDs
175
Pharmacy
166
Disability
146
Refugee
123
Planetary Health
122
Global Health Education
76
Cholera
64
Natural Hazards
58
Zika
49
Specific Hazards
44
Health Financing Toolbox
41
Polio
38
Social Ethics
26
Typhoon
3
South Sudan
1
Health Financing
1
The international community sits at the tipping pointof a post-‐antibiotic era, where common bacterial infections are no longer treatable with the antibiotic armamentarium that exists. In South Africa, t...
WHO operational handbook on tuberculosis: module 4: treatment: tuberculosis care and support
recommended
The consolidated guidelines are complemented by an operational handbook which is designed to assist with implementation of the WHO recommendations by Member States, technical partners and others who are involved in the management ... patients with DR-TB. The WHO Operational Handbook on Tuberculosis, Module 4: Treatment - Drug-Resistant Tuberculosis Treatment provides practical guidance on how to put in place the recommendations at the scale needed to achieve national and global impact.
The document provides information on different aspects of care and support for TB patients. In particular, the handbook provides practical guidance on the implementation of the interventions that enable treatment adherence such as social support, treatment administration options, digital adherence technologies. The practical guidance also includes models of care for all TB patients, models of care for children and adolescents, integrated care for TB, HIV and comorbidities, engagement of private sector, managing of TB in health emergencies. This new practical handbook also includes two important chapters on health education and counselling, and palliative care for patients with TB.
According to the World Health Organization (WHO), sub-Saharan Africa has only 3% of the world’s health workers to cater for 11% of the world population, bearing over 25% ... the global disease burden (WHO, 2014). With a steady increase in reported cases on the African Continent, the current COVID-19 pandemic threatens to overwhelm our already taxed health infrastructure. It is, therefore, imperative to take serious and urgent measures towards disease management and monitoring especially as the need for self-quarantine and contact surveillance rises.
In view of the infrastructural and resource gaps, technology should be considered for remote management of healthcare deliver to patients during this period. As it is abundantly clear, even countries with more advanced healthcare infrastructure and resources have struggled to treat COVID-19 and non-COVID-19 patients during this pandemic.
This Cardiac Rehabilitation Change Package was completed by the Centers for Disease Control and Prevention (CDC) in collaboration with the American Association of Cardiovascular and Pulmonary Rehabilitation (AACVPR) with the purpose ... helping cardiac rehabilitation programs, hospital quality improvement teams, and public health professionals who partner with these groups to implement systems and strategies that improve care for patients who are eligible for cardiac rehabilitation. AACVPR is a multidisciplinary professional association comprised of health professionals who serve in the field of cardiac and pulmonary rehabilitation.
Burns are a global public health problem, accounting for close to 200,000 deaths annually. The majority of these occur in low- and middle-income countries, where a number ... constraints complicate the public health task of addressing burns. While the primary prevention of burns in low- and middle-income countries is a pressing need, the World Health Organization (WHO) also actively encourages further development of burn-care systems, including the training of health-care providers in the appropriate triage and management of people with burns.
Therapeutics for Ebola virus disease
recommended
The WHO Ebola Virus Disease (EVD) Clinical management: living guidance contains the Organization’s most up-to-date recommendations for the clinical management of people with EVD. Providing guidance that is comprehensive and holistic for the op...
This document is a guide defining requirements for quality and safety for malaria rapid diagnostic testing services to safeguard the quality of the results, the safety of the operators and ... and that of the environment for use by national malaria control programmes, regulators, implementers and rapid diagnostic providers.
Access to NCD medicines: emergent issues during the COVID-19 pandemic and key structural factors
recommended
The coronavirus disease (COVID-19) pandemic exacerbated pre-existing inequalities in the treatment and care of noncommunicable diseases (NCDs). This report examines the effect of the COVID-19 pandem...
WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines.
Updated risk rates for hospital admission in ... with non-severe COVID-19
The guidance includes updated risk rates for hospital admission in patients with non-severe COVID-19.
The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients.
This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines:
**High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%.
**Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%.
Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk.
Review of COVID-19 treatments for people with non-severe COVID-19
WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022.
If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead.
WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission.
For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol.
WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials.
The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials.
The World Heart Federation (WHF) Roadmap series covers a large range of cardiovascular conditions. These Roadmaps identify potential roadblocks and their solutions to improve the prevention, detection and management ... cardiovascular diseases and provide a generic global framework available for local adaptation. A first Roadmap on raised blood pressure was published in 2015. Since then, advances in hypertension have included the publication of new clinical guidelines (AHA/ACC; ESC; ESH/ISH); the launch of the WHO Global HEARTS Initiative in 2016 and the associated Resolve to Save Lives (RTSL) initiative in 2017; the inclusion of single-pill combinations on the WHO Essential
Medicines’ list as well as various advances in technology, in particular telemedicine and mobile health. Given the substantial benefit accrued from effective interventions in the management of hypertension and their potential for scalability in low and middle-income countries (LMICs), the WHF has now revisited and updated the ‘Roadmap for raised BP’ as ‘Roadmap for hypertension’
by incorporating new developments in science and policy. Even though cost-effective lifestyle and medical interventions to prevent and manage hypertension exist, uptake is still low, particularly in resource-poor areas. This Roadmap examined the roadblocks pertaining to both the demand side (demographic and socio-economic factors, knowledge and beliefs, social relations, norms, and
traditions) and the supply side (health systems resources and processes) along the patient pathway to propose a range of possible solutions to overcoming them. Those include the development of population-wide prevention and control programmes; the implementation of opportunistic screening and of out-of-office blood pressure measurements; the strengthening of primary care and a greater focus on task sharing and team-based care; the delivery of people-centred care and stronger patient and carer education; and the facilitation of adherence to treatment. All of the above are dependent upon the availability and effective distribution of good quality, evidencebased, inexpensive BP-lowering agents.
The coronavirus disease (COVID-19) pandemic exacerbated pre-existing inequalities in the treatment and care of noncommunicable diseases (NCDs). This report examines the effect of the COVID-19 pandem...
The document "Chronic Respiratory Diseases: A Handbook for Pharmacists" outlines the significant role pharmacists play in managing asthma and COPD, emphasizing patient education, disease prevention, medication management, and promoting healthy lifes...
Background
Asthma education, a key component of long-term asthma management, is challenging in resource-limited settings with shortages of clinical staff. Task-shifting educational roles to lay (no...
Forcibly Displaced Myanmar National / Rohingya Refugee Response.
This document gives guidance for medical providers to understand the care of both healthy and COVID suspect or confirmed patients wh...
The 2019 ANA’s Principles for Nurse Staffing, Third Edition, identifies major elements needed to achieve appropriate nurse staffing, which enhances the delivery of safe, quality health care. These principles are grounded in the substantive and gro...
Arsenical monotherapies were previously very successful for treating human African trypanosomiasis (HAT).
Melarsoprol resistance emerged as early as the 1970s and was widespread by the late 1990s.
Melarsoprol resistance represents the only example of...
Zika and dengue viruses remain significant public health threats. These viruses share the same Aedes (Stegomyia) mosquito vectors and geographic distributions but infections cannot be readily distinguished clinically and need to be differentiated from each other, and from other circulating arboviral...
In 2015, WHO proposed the use of the Robson classification (also known as the 10-group classification) as a global standard for assessing, monitoring and comparing caesarean section rates both within healthcare facilities and between them. The syst...
Using antimicrobials responsibly is an essential component ofefforts to contain antimicrobial resistance (AMR), and to ensurethat patients receive appropriate treatment. The WHO global action plan on AMR emphasizes the importance ... training healthcare professionals in antimicrobial prescribing and stew-ardship (AMPS). There are several challenges, however, such asthe wide range of healthcare professionals involved in the pre-scribing process, and the heterogeneity of prescribing rights and practices of different professional groups within and between countries. One way to address these challenges is through developing competencies, which define the minimum standards that all antimicrobial prescribers should reach.
Clinical Microbiology and Infection 25 (2019) 13e19
This guidance note developed by UNICEF explains how the WASH sector can implement infection prevention and control measures in households and community settings. It focuses on reducing the exposure to the disease in vulnerable community settings and public spaces, and the transmission ... the disease in home and community settings hosting patients and contacts. This brief is available in English, Spanish, and French here.
